nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—atopic dermatitis—psoriasis	0.0588	0.375	CtDrD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Fluocinonide—psoriasis	0.0584	0.226	CiPCiCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Fluocinolone Acetonide—psoriasis	0.0584	0.226	CiPCiCtD
Hydrocortisone—systemic lupus erythematosus—psoriasis	0.0505	0.322	CtDrD
Hydrocortisone—rheumatoid arthritis—psoriasis	0.0477	0.304	CtDrD
Hydrocortisone—kidney cancer—Dexamethasone—psoriasis	0.0345	0.29	CpDpCtD
Hydrocortisone—kidney cancer—Betamethasone—psoriasis	0.0345	0.29	CpDpCtD
Hydrocortisone—Betamethasone—psoriasis	0.034	0.208	CrCtD
Hydrocortisone—Dexamethasone—psoriasis	0.034	0.208	CrCtD
Hydrocortisone—Triamcinolone—psoriasis	0.0332	0.203	CrCtD
Hydrocortisone—Prednisone—psoriasis	0.0315	0.193	CrCtD
Hydrocortisone—Prednisolone—psoriasis	0.0308	0.188	CrCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Betamethasone—psoriasis	0.0295	0.114	CiPCiCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—psoriasis	0.0295	0.114	CiPCiCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—psoriasis	0.0285	0.111	CiPCiCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Prednisolone—psoriasis	0.0276	0.107	CiPCiCtD
Hydrocortisone—Corticosteroid Hormone Receptor Agonists—Prednisone—psoriasis	0.0261	0.101	CiPCiCtD
Hydrocortisone—prostate cancer—Betamethasone—psoriasis	0.025	0.21	CpDpCtD
Hydrocortisone—prostate cancer—Dexamethasone—psoriasis	0.025	0.21	CpDpCtD
Hydrocortisone—ANXA1—Dexamethasone—psoriasis	0.0153	0.136	CbGbCtD
Hydrocortisone—NR3C1—Clobetasol propionate—psoriasis	0.0118	0.105	CbGbCtD
Hydrocortisone—NR3C1—Fluocinonide—psoriasis	0.00898	0.0799	CbGbCtD
Hydrocortisone—NR3C1—Beclomethasone—psoriasis	0.00898	0.0799	CbGbCtD
Hydrocortisone—NR3C1—Fluocinolone Acetonide—psoriasis	0.00898	0.0799	CbGbCtD
Hydrocortisone—NR3C1—Triamcinolone—psoriasis	0.00357	0.0318	CbGbCtD
Hydrocortisone—CYP2C8—Tazarotene—psoriasis	0.00332	0.0296	CbGbCtD
Hydrocortisone—CYP3A5—Beclomethasone—psoriasis	0.00321	0.0286	CbGbCtD
Hydrocortisone—NR3C1—Betamethasone—psoriasis	0.00307	0.0273	CbGbCtD
Hydrocortisone—NR3C1—Prednisolone—psoriasis	0.00303	0.0269	CbGbCtD
Hydrocortisone—NR3C1—Prednisone—psoriasis	0.00286	0.0254	CbGbCtD
Hydrocortisone—SLCO1A2—Prednisolone—psoriasis	0.00261	0.0232	CbGbCtD
Hydrocortisone—SLCO1A2—Prednisone—psoriasis	0.00246	0.0219	CbGbCtD
Hydrocortisone—SLCO1A2—Cyclosporine—psoriasis	0.00233	0.0208	CbGbCtD
Hydrocortisone—ABCG2—Mycophenolate mofetil—psoriasis	0.00231	0.0206	CbGbCtD
Hydrocortisone—Ciclesonide—Clobetasol propionate—psoriasis	0.00203	0.0148	CrCrCtD
Hydrocortisone—NR3C1—Dexamethasone—psoriasis	0.00178	0.0159	CbGbCtD
Hydrocortisone—ABCG2—Cyclosporine—psoriasis	0.00175	0.0156	CbGbCtD
Hydrocortisone—Ciclesonide—Beclomethasone—psoriasis	0.00163	0.0118	CrCrCtD
Hydrocortisone—Ciclesonide—Fluocinonide—psoriasis	0.00163	0.0118	CrCrCtD
Hydrocortisone—Prednicarbate—Clobetasol propionate—psoriasis	0.0016	0.0116	CrCrCtD
Hydrocortisone—SLCO1A2—Dexamethasone—psoriasis	0.00154	0.0137	CbGbCtD
Hydrocortisone—Alclometasone—Clobetasol propionate—psoriasis	0.00151	0.011	CrCrCtD
Hydrocortisone—Budesonide—Clobetasol propionate—psoriasis	0.00147	0.0107	CrCrCtD
Hydrocortisone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.00147	0.0107	CrCrCtD
Hydrocortisone—Flurandrenolide—Fluocinonide—psoriasis	0.00146	0.0106	CrCrCtD
Hydrocortisone—Prednisone—Clobetasol propionate—psoriasis	0.00143	0.0104	CrCrCtD
Hydrocortisone—Fludrocortisone—Clobetasol propionate—psoriasis	0.00143	0.0104	CrCrCtD
Hydrocortisone—Desonide—Clobetasol propionate—psoriasis	0.00143	0.0104	CrCrCtD
Hydrocortisone—CYP2C8—Cholecalciferol—psoriasis	0.00142	0.0126	CbGbCtD
Hydrocortisone—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.00142	0.0103	CrCrCtD
Hydrocortisone—Paramethasone—Clobetasol propionate—psoriasis	0.0014	0.0101	CrCrCtD
Hydrocortisone—Hydrocortamate—Beclomethasone—psoriasis	0.00136	0.00989	CrCrCtD
Hydrocortisone—Desoximetasone—Clobetasol propionate—psoriasis	0.00136	0.00989	CrCrCtD
Hydrocortisone—Fluorometholone—Clobetasol propionate—psoriasis	0.00133	0.00966	CrCrCtD
Hydrocortisone—Triamcinolone—Clobetasol propionate—psoriasis	0.00133	0.00966	CrCrCtD
Hydrocortisone—Mometasone—Clobetasol propionate—psoriasis	0.00133	0.00966	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00133	0.00966	CrCrCtD
Hydrocortisone—Loteprednol—Clobetasol propionate—psoriasis	0.00133	0.00966	CrCrCtD
Hydrocortisone—Dexamethasone—Clobetasol propionate—psoriasis	0.0013	0.00944	CrCrCtD
Hydrocortisone—Rimexolone—Clobetasol propionate—psoriasis	0.0013	0.00944	CrCrCtD
Hydrocortisone—Betamethasone—Clobetasol propionate—psoriasis	0.0013	0.00944	CrCrCtD
Hydrocortisone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00129	0.0115	CbGbCtD
Hydrocortisone—CYP3A7—Cyclosporine—psoriasis	0.00129	0.0115	CbGbCtD
Hydrocortisone—Prednicarbate—Beclomethasone—psoriasis	0.00128	0.0093	CrCrCtD
Hydrocortisone—CYP3A5—Mycophenolate mofetil—psoriasis	0.00128	0.0114	CbGbCtD
Hydrocortisone—Methylprednisolone—Clobetasol propionate—psoriasis	0.00124	0.00903	CrCrCtD
Hydrocortisone—SLCO1A2—Methotrexate—psoriasis	0.00124	0.011	CbGbCtD
Hydrocortisone—CYP2C8—Mycophenolate mofetil—psoriasis	0.00123	0.0109	CbGbCtD
Hydrocortisone—Prednisolone—Clobetasol propionate—psoriasis	0.00122	0.00884	CrCrCtD
Hydrocortisone—Alclometasone—Beclomethasone—psoriasis	0.00121	0.00879	CrCrCtD
Hydrocortisone—Budesonide—Fluocinonide—psoriasis	0.00118	0.00855	CrCrCtD
Hydrocortisone—Budesonide—Beclomethasone—psoriasis	0.00118	0.00855	CrCrCtD
Hydrocortisone—Alclometasone—Fluocinolone Acetonide—psoriasis	0.00118	0.00854	CrCrCtD
Hydrocortisone—ABCG2—Dexamethasone—psoriasis	0.00115	0.0103	CbGbCtD
Hydrocortisone—Desonide—Fluocinonide—psoriasis	0.00115	0.00833	CrCrCtD
Hydrocortisone—Flunisolide—Fluocinonide—psoriasis	0.00115	0.00833	CrCrCtD
Hydrocortisone—Desonide—Beclomethasone—psoriasis	0.00115	0.00833	CrCrCtD
Hydrocortisone—Budesonide—Fluocinolone Acetonide—psoriasis	0.00114	0.00831	CrCrCtD
Hydrocortisone—Paramethasone—Fluocinonide—psoriasis	0.00112	0.00812	CrCrCtD
Hydrocortisone—CYP3A4—Calcitriol—psoriasis	0.00112	0.00994	CbGbCtD
Hydrocortisone—Flunisolide—Fluocinolone Acetonide—psoriasis	0.00111	0.00809	CrCrCtD
Hydrocortisone—Desonide—Fluocinolone Acetonide—psoriasis	0.00111	0.00809	CrCrCtD
Hydrocortisone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.00111	0.00809	CrCrCtD
Hydrocortisone—Desoximetasone—Fluocinonide—psoriasis	0.00109	0.00792	CrCrCtD
Hydrocortisone—Desoximetasone—Beclomethasone—psoriasis	0.00109	0.00792	CrCrCtD
Hydrocortisone—Paramethasone—Fluocinolone Acetonide—psoriasis	0.00109	0.00789	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Fluorometholone—Fluocinonide—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Loteprednol—Beclomethasone—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Mometasone—Fluocinonide—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Fluorometholone—Beclomethasone—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Triamcinolone—Fluocinonide—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Triamcinolone—Beclomethasone—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Mometasone—Beclomethasone—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.00107	0.00774	CrCrCtD
Hydrocortisone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.00106	0.0077	CrCrCtD
Hydrocortisone—Betamethasone—Beclomethasone—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Betamethasone—Fluocinonide—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Rimexolone—Beclomethasone—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Dexamethasone—Beclomethasone—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Rimexolone—Fluocinonide—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Dexamethasone—Fluocinonide—psoriasis	0.00104	0.00756	CrCrCtD
Hydrocortisone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.00104	0.00752	CrCrCtD
Hydrocortisone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.00104	0.00752	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.00104	0.00752	CrCrCtD
Hydrocortisone—Mometasone—Fluocinolone Acetonide—psoriasis	0.00104	0.00752	CrCrCtD
Hydrocortisone—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00101	0.00735	CrCrCtD
Hydrocortisone—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00101	0.00735	CrCrCtD
Hydrocortisone—Rimexolone—Fluocinolone Acetonide—psoriasis	0.00101	0.00735	CrCrCtD
Hydrocortisone—Methylprednisolone—Fluocinonide—psoriasis	0.000996	0.00723	CrCrCtD
Hydrocortisone—Prednisolone—Beclomethasone—psoriasis	0.000975	0.00708	CrCrCtD
Hydrocortisone—CYP3A5—Cyclosporine—psoriasis	0.000969	0.00863	CbGbCtD
Hydrocortisone—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.000968	0.00703	CrCrCtD
Hydrocortisone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.000947	0.00688	CrCrCtD
Hydrocortisone—CYP2C8—Cyclosporine—psoriasis	0.000932	0.0083	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—psoriasis	0.000926	0.00824	CbGbCtD
Hydrocortisone—CYP3A4—Methoxsalen—psoriasis	0.000868	0.00773	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.000851	0.00758	CbGbCtD
Hydrocortisone—CYP3A7—Dexamethasone—psoriasis	0.000851	0.00758	CbGbCtD
Hydrocortisone—ABCB1—Mycophenolate mofetil—psoriasis	0.000832	0.00741	CbGbCtD
Hydrocortisone—Potassium Canrenoate—Prednisone—psoriasis	0.000784	0.00569	CrCrCtD
Hydrocortisone—Potassium Canrenoate—Prednisolone—psoriasis	0.000765	0.00556	CrCrCtD
Hydrocortisone—ABCB1—Betamethasone—psoriasis	0.000714	0.00636	CbGbCtD
Hydrocortisone—ABCB1—Prednisolone—psoriasis	0.000705	0.00627	CbGbCtD
Hydrocortisone—Ciclesonide—Prednisone—psoriasis	0.000688	0.005	CrCrCtD
Hydrocortisone—Ciclesonide—Prednisolone—psoriasis	0.000672	0.00488	CrCrCtD
Hydrocortisone—ABCB1—Prednisone—psoriasis	0.000665	0.00592	CbGbCtD
Hydrocortisone—Flurandrenolide—Dexamethasone—psoriasis	0.000664	0.00482	CrCrCtD
Hydrocortisone—Flurandrenolide—Betamethasone—psoriasis	0.000664	0.00482	CrCrCtD
Hydrocortisone—Danazol—Prednisone—psoriasis	0.000662	0.00481	CrCrCtD
Hydrocortisone—Medrysone—Prednisolone—psoriasis	0.000646	0.00469	CrCrCtD
Hydrocortisone—CYP3A5—Dexamethasone—psoriasis	0.000638	0.00568	CbGbCtD
Hydrocortisone—ABCB1—Cyclosporine—psoriasis	0.000631	0.00562	CbGbCtD
Hydrocortisone—CYP2C8—Dexamethasone—psoriasis	0.000614	0.00546	CbGbCtD
Hydrocortisone—Flurandrenolide—Prednisolone—psoriasis	0.000601	0.00436	CrCrCtD
Hydrocortisone—Prednicarbate—Betamethasone—psoriasis	0.000584	0.00424	CrCrCtD
Hydrocortisone—Prednicarbate—Dexamethasone—psoriasis	0.000584	0.00424	CrCrCtD
Hydrocortisone—Hydrocortamate—Prednisone—psoriasis	0.000576	0.00418	CrCrCtD
Hydrocortisone—CYP3A4—Cholecalciferol—psoriasis	0.000575	0.00512	CbGbCtD
Hydrocortisone—Prednicarbate—Triamcinolone—psoriasis	0.00057	0.00414	CrCrCtD
Hydrocortisone—Hydrocortamate—Prednisolone—psoriasis	0.000562	0.00408	CrCrCtD
Hydrocortisone—Cortisone acetate—Prednisone—psoriasis	0.000558	0.00405	CrCrCtD
Hydrocortisone—Alclometasone—Dexamethasone—psoriasis	0.000551	0.004	CrCrCtD
Hydrocortisone—Alclometasone—Betamethasone—psoriasis	0.000551	0.004	CrCrCtD
Hydrocortisone—Cortisone acetate—Prednisolone—psoriasis	0.000545	0.00396	CrCrCtD
Hydrocortisone—Prednicarbate—Prednisone—psoriasis	0.000541	0.00393	CrCrCtD
Hydrocortisone—Alclometasone—Triamcinolone—psoriasis	0.000539	0.00391	CrCrCtD
Hydrocortisone—Budesonide—Dexamethasone—psoriasis	0.000537	0.0039	CrCrCtD
Hydrocortisone—Fluoxymesterone—Betamethasone—psoriasis	0.000537	0.0039	CrCrCtD
Hydrocortisone—Fluoxymesterone—Dexamethasone—psoriasis	0.000537	0.0039	CrCrCtD
Hydrocortisone—Budesonide—Betamethasone—psoriasis	0.000537	0.0039	CrCrCtD
Hydrocortisone—Prednicarbate—Prednisolone—psoriasis	0.000528	0.00384	CrCrCtD
Hydrocortisone—Budesonide—Triamcinolone—psoriasis	0.000524	0.00381	CrCrCtD
Hydrocortisone—Fluoxymesterone—Triamcinolone—psoriasis	0.000524	0.00381	CrCrCtD
Hydrocortisone—Fludrocortisone—Dexamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Desonide—Betamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Desonide—Dexamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Prednisone—Betamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Prednisone—Dexamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Fludrocortisone—Betamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Flunisolide—Betamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Flunisolide—Dexamethasone—psoriasis	0.000523	0.0038	CrCrCtD
Hydrocortisone—Alclometasone—Prednisone—psoriasis	0.000511	0.00371	CrCrCtD
Hydrocortisone—Desonide—Triamcinolone—psoriasis	0.000511	0.00371	CrCrCtD
Hydrocortisone—Flunisolide—Triamcinolone—psoriasis	0.000511	0.00371	CrCrCtD
Hydrocortisone—Prednisone—Triamcinolone—psoriasis	0.000511	0.00371	CrCrCtD
Hydrocortisone—Fludrocortisone—Triamcinolone—psoriasis	0.000511	0.00371	CrCrCtD
Hydrocortisone—Paramethasone—Betamethasone—psoriasis	0.00051	0.0037	CrCrCtD
Hydrocortisone—Paramethasone—Dexamethasone—psoriasis	0.00051	0.0037	CrCrCtD
Hydrocortisone—Alclometasone—Prednisolone—psoriasis	0.000499	0.00362	CrCrCtD
Hydrocortisone—CYP3A4—Mycophenolate mofetil—psoriasis	0.000499	0.00444	CbGbCtD
Hydrocortisone—CYP3A4—Triamcinolone—psoriasis	0.000499	0.00444	CbGbCtD
Hydrocortisone—Paramethasone—Triamcinolone—psoriasis	0.000498	0.00362	CrCrCtD
Hydrocortisone—Budesonide—Prednisone—psoriasis	0.000498	0.00361	CrCrCtD
Hydrocortisone—Desoximetasone—Dexamethasone—psoriasis	0.000497	0.00361	CrCrCtD
Hydrocortisone—Desoximetasone—Betamethasone—psoriasis	0.000497	0.00361	CrCrCtD
Hydrocortisone—Desoximetasone—Triamcinolone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Budesonide—Prednisolone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fluoxymesterone—Prednisolone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Triamcinolone—Dexamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Mometasone—Betamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fluorometholone—Betamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Mometasone—Dexamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Betamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Dexamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Loteprednol—Dexamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Loteprednol—Betamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Triamcinolone—Betamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fluorometholone—Dexamethasone—psoriasis	0.000486	0.00353	CrCrCtD
Hydrocortisone—Fludrocortisone—Prednisone—psoriasis	0.000485	0.00352	CrCrCtD
Hydrocortisone—Desonide—Prednisone—psoriasis	0.000485	0.00352	CrCrCtD
Hydrocortisone—Flunisolide—Prednisone—psoriasis	0.000485	0.00352	CrCrCtD
Hydrocortisone—Rimexolone—Dexamethasone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Rimexolone—Betamethasone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Betamethasone—Dexamethasone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Dexamethasone—Betamethasone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Fluorometholone—Triamcinolone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Mometasone—Triamcinolone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Loteprednol—Triamcinolone—psoriasis	0.000474	0.00344	CrCrCtD
Hydrocortisone—Desonide—Prednisolone—psoriasis	0.000473	0.00344	CrCrCtD
Hydrocortisone—Prednisone—Prednisolone—psoriasis	0.000473	0.00344	CrCrCtD
Hydrocortisone—Fludrocortisone—Prednisolone—psoriasis	0.000473	0.00344	CrCrCtD
Hydrocortisone—Progesterone—Prednisolone—psoriasis	0.000473	0.00344	CrCrCtD
Hydrocortisone—Flunisolide—Prednisolone—psoriasis	0.000473	0.00344	CrCrCtD
Hydrocortisone—Methyltestosterone—Prednisone—psoriasis	0.000473	0.00343	CrCrCtD
Hydrocortisone—Paramethasone—Prednisone—psoriasis	0.000473	0.00343	CrCrCtD
Hydrocortisone—Dexamethasone—Triamcinolone—psoriasis	0.000464	0.00337	CrCrCtD
Hydrocortisone—Rimexolone—Triamcinolone—psoriasis	0.000464	0.00337	CrCrCtD
Hydrocortisone—Betamethasone—Triamcinolone—psoriasis	0.000464	0.00337	CrCrCtD
Hydrocortisone—Paramethasone—Prednisolone—psoriasis	0.000461	0.00335	CrCrCtD
Hydrocortisone—Methyltestosterone—Prednisolone—psoriasis	0.000461	0.00335	CrCrCtD
Hydrocortisone—Desoximetasone—Prednisone—psoriasis	0.000461	0.00335	CrCrCtD
Hydrocortisone—Methylprednisolone—Betamethasone—psoriasis	0.000454	0.0033	CrCrCtD
Hydrocortisone—Methylprednisolone—Dexamethasone—psoriasis	0.000454	0.0033	CrCrCtD
Hydrocortisone—Mometasone—Prednisone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Prednisone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Loteprednol—Prednisone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Fluorometholone—Prednisone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Triamcinolone—Prednisone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Desoximetasone—Prednisolone—psoriasis	0.00045	0.00327	CrCrCtD
Hydrocortisone—Prednisolone—Betamethasone—psoriasis	0.000444	0.00323	CrCrCtD
Hydrocortisone—Prednisolone—Dexamethasone—psoriasis	0.000444	0.00323	CrCrCtD
Hydrocortisone—Methylprednisolone—Triamcinolone—psoriasis	0.000443	0.00322	CrCrCtD
Hydrocortisone—Dexamethasone—Prednisone—psoriasis	0.00044	0.00319	CrCrCtD
Hydrocortisone—Betamethasone—Prednisone—psoriasis	0.00044	0.00319	CrCrCtD
Hydrocortisone—Rimexolone—Prednisone—psoriasis	0.00044	0.00319	CrCrCtD
Hydrocortisone—Loteprednol—Prednisolone—psoriasis	0.000439	0.00319	CrCrCtD
Hydrocortisone—Fluprednidene Acetate—Prednisolone—psoriasis	0.000439	0.00319	CrCrCtD
Hydrocortisone—Mometasone—Prednisolone—psoriasis	0.000439	0.00319	CrCrCtD
Hydrocortisone—Triamcinolone—Prednisolone—psoriasis	0.000439	0.00319	CrCrCtD
Hydrocortisone—Fluorometholone—Prednisolone—psoriasis	0.000439	0.00319	CrCrCtD
Hydrocortisone—Prednisolone—Triamcinolone—psoriasis	0.000434	0.00315	CrCrCtD
Hydrocortisone—Rimexolone—Prednisolone—psoriasis	0.000429	0.00312	CrCrCtD
Hydrocortisone—Dexamethasone—Prednisolone—psoriasis	0.000429	0.00312	CrCrCtD
Hydrocortisone—Betamethasone—Prednisolone—psoriasis	0.000429	0.00312	CrCrCtD
Hydrocortisone—CYP3A4—Betamethasone—psoriasis	0.000428	0.00381	CbGbCtD
Hydrocortisone—CYP3A4—Prednisolone—psoriasis	0.000422	0.00376	CbGbCtD
Hydrocortisone—Methylprednisolone—Prednisone—psoriasis	0.000421	0.00306	CrCrCtD
Hydrocortisone—ABCB1—Dexamethasone—psoriasis	0.000415	0.0037	CbGbCtD
Hydrocortisone—Prednisolone—Prednisone—psoriasis	0.000412	0.00299	CrCrCtD
Hydrocortisone—Methylprednisolone—Prednisolone—psoriasis	0.000411	0.00298	CrCrCtD
Hydrocortisone—Testosterone—Prednisolone—psoriasis	0.000411	0.00298	CrCrCtD
Hydrocortisone—CYP3A4—Prednisone—psoriasis	0.000399	0.00355	CbGbCtD
Hydrocortisone—CYP3A4—Cyclosporine—psoriasis	0.000378	0.00336	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—psoriasis	0.000334	0.00297	CbGbCtD
Hydrocortisone—CYP3A4—Dexamethasone—psoriasis	0.000249	0.00222	CbGbCtD
Hydrocortisone—CYP11B1—Biological oxidations—CYP2S1—psoriasis	7.11e-05	0.0108	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metapathway biotransformation—CYP2S1—psoriasis	7.01e-05	0.0106	CbGpPWpGaD
Hydrocortisone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.59e-05	0.00996	CbGpPWpGaD
Hydrocortisone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	6.57e-05	0.00994	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.56e-05	0.00993	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CCL20—psoriasis	5.96e-05	0.00902	CbGpPWpGaD
Hydrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	5.93e-05	0.00897	CbGpPWpGaD
Hydrocortisone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.87e-05	0.00888	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—HCAR2—psoriasis	5.86e-05	0.00887	CbGpPWpGaD
Hydrocortisone—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.8e-05	0.00876	CbGpPWpGaD
Hydrocortisone—ABCG2—Iron uptake and transport—CP—psoriasis	5.48e-05	0.00828	CbGpPWpGaD
Hydrocortisone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	5.09e-05	0.00769	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CCL20—psoriasis	5.03e-05	0.00761	CbGpPWpGaD
Hydrocortisone—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	5.02e-05	0.00759	CbGpPWpGaD
Hydrocortisone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.76e-05	0.0072	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	4.52e-05	0.00683	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	4.45e-05	0.00673	CbGpPWpGaD
Hydrocortisone—NR3C1—Circadian Clock—CARM1—psoriasis	4.32e-05	0.00653	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	4.3e-05	0.0065	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL4—psoriasis	4.19e-05	0.00634	CbGpPWpGaD
Hydrocortisone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	4.12e-05	0.00624	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	4e-05	0.00605	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	3.89e-05	0.00588	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	3.74e-05	0.00566	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	3.73e-05	0.00564	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—LEP—psoriasis	3.55e-05	0.00536	CbGpPWpGaD
Hydrocortisone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	3.54e-05	0.00536	CbGpPWpGaD
Hydrocortisone—CYP3A7—Biological oxidations—CYP2S1—psoriasis	3.5e-05	0.00529	CbGpPWpGaD
Hydrocortisone—NR3C1—Nuclear Receptors—VDR—psoriasis	3.47e-05	0.00524	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	3.45e-05	0.00522	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—ICAM1—psoriasis	3.33e-05	0.00504	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—HCAR2—psoriasis	3.31e-05	0.00501	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—NOS2—psoriasis	3.3e-05	0.005	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CCL20—psoriasis	3.04e-05	0.00461	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HCAR2—psoriasis	3.01e-05	0.00455	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	2.91e-05	0.00441	CbGpPWpGaD
Hydrocortisone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	2.74e-05	0.00414	CbGpPWpGaD
Hydrocortisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	2.73e-05	0.00413	CbGpPWpGaD
Hydrocortisone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	2.69e-05	0.00407	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.68e-05	0.00405	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	2.55e-05	0.00386	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IFNG—psoriasis	2.53e-05	0.00383	CbGpPWpGaD
Hydrocortisone—CYP3A5—Biological oxidations—CYP2S1—psoriasis	2.53e-05	0.00382	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	2.49e-05	0.00377	CbGpPWpGaD
Hydrocortisone—NR3C1—Nuclear Receptors—PPARG—psoriasis	2.42e-05	0.00365	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—CXCL8—psoriasis	2.36e-05	0.00356	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.25e-05	0.0034	CbGpPWpGaD
Hydrocortisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	2.21e-05	0.00335	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	2.21e-05	0.00334	CbGpPWpGaD
Hydrocortisone—CYP2C8—Biological oxidations—CYP2S1—psoriasis	2.19e-05	0.00331	CbGpPWpGaD
Hydrocortisone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	2.18e-05	0.0033	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	2.16e-05	0.00327	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	2.1e-05	0.00318	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	2.07e-05	0.00313	CbGpPWpGaD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.04e-05	0.00308	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	2.01e-05	0.00304	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	1.99e-05	0.00301	CbGpPWpGaD
Hydrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	1.91e-05	0.00289	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	1.89e-05	0.00286	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	1.84e-05	0.00278	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	1.82e-05	0.00276	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	1.82e-05	0.00275	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.8e-05	0.00272	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HCAR2—psoriasis	1.78e-05	0.00269	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	1.77e-05	0.00268	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	1.77e-05	0.00268	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	1.74e-05	0.00263	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.73e-05	0.00262	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CCL20—psoriasis	1.72e-05	0.0026	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	1.67e-05	0.00253	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—NDUFA5—psoriasis	1.66e-05	0.00251	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	1.65e-05	0.0025	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TNF—psoriasis	1.64e-05	0.00248	CbGpPWpGaD
Hydrocortisone—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	1.64e-05	0.00248	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	1.63e-05	0.00246	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	1.63e-05	0.00246	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-C—psoriasis	1.62e-05	0.00245	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL13—psoriasis	1.61e-05	0.00244	CbGpPWpGaD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCL8—psoriasis	1.61e-05	0.00243	CbGpPWpGaD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	1.6e-05	0.00243	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.57e-05	0.00238	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CCL20—psoriasis	1.56e-05	0.00236	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.55e-05	0.00234	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TAGAP—psoriasis	1.54e-05	0.00233	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.49e-05	0.00225	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL17A—psoriasis	1.48e-05	0.00224	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—psoriasis	1.45e-05	0.00219	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.43e-05	0.00217	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—NDUFA5—psoriasis	1.43e-05	0.00216	CbGpPWpGaD
Hydrocortisone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.42e-05	0.00215	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CYP2S1—psoriasis	1.41e-05	0.00213	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	1.41e-05	0.00213	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—SOCS1—psoriasis	1.41e-05	0.00213	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL12B—psoriasis	1.38e-05	0.00209	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCL8—psoriasis	1.36e-05	0.00205	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-E—psoriasis	1.35e-05	0.00204	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.33e-05	0.00202	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL6—psoriasis	1.32e-05	0.002	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	1.31e-05	0.00199	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.3e-05	0.00197	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	1.26e-05	0.0019	CbGpPWpGaD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	1.25e-05	0.0019	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	1.22e-05	0.00184	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CYP2S1—psoriasis	1.22e-05	0.00184	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—TARS—psoriasis	1.21e-05	0.00183	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.19e-05	0.0018	CbGpPWpGaD
Hydrocortisone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	1.18e-05	0.00178	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	1.16e-05	0.00175	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	1.13e-05	0.00171	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.12e-05	0.00169	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.11e-05	0.00169	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	1.1e-05	0.00166	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	1.09e-05	0.00165	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	1.08e-05	0.00163	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	1.07e-05	0.00162	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	1.05e-05	0.00159	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—LEP—psoriasis	1.04e-05	0.00157	CbGpPWpGaD
Hydrocortisone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	1.01e-05	0.00153	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL10—psoriasis	1.01e-05	0.00153	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	9.96e-06	0.00151	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.84e-06	0.00149	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL4—psoriasis	9.81e-06	0.00148	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-B—psoriasis	9.59e-06	0.00145	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	9.58e-06	0.00145	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	9.57e-06	0.00145	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	9.36e-06	0.00141	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	9.26e-06	0.0014	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCL20—psoriasis	9.23e-06	0.0014	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—PPARG—psoriasis	9.03e-06	0.00137	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—NDUFA5—psoriasis	8.97e-06	0.00136	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	8.93e-06	0.00135	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	8.92e-06	0.00135	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-A—psoriasis	8.89e-06	0.00134	CbGpPWpGaD
Hydrocortisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.74e-06	0.00132	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.36e-06	0.00126	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	8.33e-06	0.00126	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCL8—psoriasis	8.22e-06	0.00124	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	8.19e-06	0.00124	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	8.12e-06	0.00123	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	7.95e-06	0.0012	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	7.92e-06	0.0012	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CYP2S1—psoriasis	7.62e-06	0.00115	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.39e-06	0.00112	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—NDUFA5—psoriasis	7.1e-06	0.00107	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—NDUFA5—psoriasis	7.04e-06	0.00106	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	6.94e-06	0.00105	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—CARM1—psoriasis	6.89e-06	0.00104	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	6.6e-06	0.000998	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.44e-06	0.000974	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.37e-06	0.000964	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	6.35e-06	0.000961	CbGpPWpGaD
Hydrocortisone—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	6.29e-06	0.000952	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	6.12e-06	0.000925	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CYP2S1—psoriasis	6.04e-06	0.000913	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CYP2S1—psoriasis	5.98e-06	0.000905	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.96e-06	0.000901	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—CARM1—psoriasis	5.94e-06	0.000898	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IFNG—psoriasis	5.93e-06	0.000897	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	5.92e-06	0.000895	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	5.6e-06	0.000847	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.55e-06	0.000839	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—STAT3—psoriasis	5.54e-06	0.000838	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	5.54e-06	0.000838	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.52e-06	0.000834	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.33e-06	0.000806	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.17e-06	0.000782	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—NDUFA5—psoriasis	5.09e-06	0.000769	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SOCS1—psoriasis	5.08e-06	0.000769	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—TYK2—psoriasis	4.85e-06	0.000733	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.84e-06	0.000732	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—TNF—psoriasis	4.8e-06	0.000726	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	4.73e-06	0.000716	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCL8—psoriasis	4.65e-06	0.000703	CbGpPWpGaD
Hydrocortisone—Dyspepsia—Mycophenolate mofetil—psoriasis	4.62e-06	0.000101	CcSEcCtD
Hydrocortisone—Pain—Cyclosporine—psoriasis	4.61e-06	0.0001	CcSEcCtD
Hydrocortisone—Angioedema—Betamethasone—psoriasis	4.58e-06	9.97e-05	CcSEcCtD
Hydrocortisone—Angioedema—Dexamethasone—psoriasis	4.58e-06	9.97e-05	CcSEcCtD
Hydrocortisone—Decreased appetite—Mycophenolate mofetil—psoriasis	4.57e-06	9.95e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Mycophenolic acid—psoriasis	4.55e-06	9.92e-05	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.54e-06	0.000687	CbGpPWpGaD
Hydrocortisone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	4.54e-06	9.88e-05	CcSEcCtD
Hydrocortisone—Immune system disorder—Prednisone—psoriasis	4.53e-06	9.86e-05	CcSEcCtD
Hydrocortisone—Malaise—Betamethasone—psoriasis	4.52e-06	9.84e-05	CcSEcCtD
Hydrocortisone—Malaise—Dexamethasone—psoriasis	4.52e-06	9.84e-05	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Triamcinolone—psoriasis	4.51e-06	9.82e-05	CcSEcCtD
Hydrocortisone—Oedema—Triamcinolone—psoriasis	4.51e-06	9.82e-05	CcSEcCtD
Hydrocortisone—Vertigo—Dexamethasone—psoriasis	4.5e-06	9.81e-05	CcSEcCtD
Hydrocortisone—Vertigo—Betamethasone—psoriasis	4.5e-06	9.81e-05	CcSEcCtD
Hydrocortisone—Syncope—Dexamethasone—psoriasis	4.49e-06	9.79e-05	CcSEcCtD
Hydrocortisone—Syncope—Betamethasone—psoriasis	4.49e-06	9.79e-05	CcSEcCtD
Hydrocortisone—Pain—Mycophenolate mofetil—psoriasis	4.49e-06	9.79e-05	CcSEcCtD
Hydrocortisone—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.48e-06	0.000677	CbGpPWpGaD
Hydrocortisone—Arrhythmia—Prednisone—psoriasis	4.48e-06	9.75e-05	CcSEcCtD
Hydrocortisone—Infection—Triamcinolone—psoriasis	4.48e-06	9.75e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Cyclosporine—psoriasis	4.44e-06	9.67e-05	CcSEcCtD
Hydrocortisone—Shock—Triamcinolone—psoriasis	4.43e-06	9.66e-05	CcSEcCtD
Hydrocortisone—Insomnia—Prednisolone—psoriasis	4.43e-06	9.66e-05	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism—NDUFA5—psoriasis	4.41e-06	0.000666	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Cyclosporine—psoriasis	4.4e-06	9.59e-05	CcSEcCtD
Hydrocortisone—Loss of consciousness—Dexamethasone—psoriasis	4.4e-06	9.59e-05	CcSEcCtD
Hydrocortisone—Loss of consciousness—Betamethasone—psoriasis	4.4e-06	9.59e-05	CcSEcCtD
Hydrocortisone—Dizziness—Mycophenolic acid—psoriasis	4.4e-06	9.59e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Prednisolone—psoriasis	4.4e-06	9.59e-05	CcSEcCtD
Hydrocortisone—Tachycardia—Triamcinolone—psoriasis	4.4e-06	9.58e-05	CcSEcCtD
Hydrocortisone—Mental disorder—Prednisone—psoriasis	4.39e-06	9.57e-05	CcSEcCtD
Hydrocortisone—Malnutrition—Prednisone—psoriasis	4.36e-06	9.51e-05	CcSEcCtD
Hydrocortisone—Erythema—Prednisone—psoriasis	4.36e-06	9.51e-05	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Triamcinolone—psoriasis	4.36e-06	9.49e-05	CcSEcCtD
Hydrocortisone—Convulsion—Dexamethasone—psoriasis	4.34e-06	9.46e-05	CcSEcCtD
Hydrocortisone—Convulsion—Betamethasone—psoriasis	4.34e-06	9.46e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.33e-06	9.43e-05	CcSEcCtD
Hydrocortisone—Hypertension—Dexamethasone—psoriasis	4.33e-06	9.42e-05	CcSEcCtD
Hydrocortisone—Hypertension—Betamethasone—psoriasis	4.33e-06	9.42e-05	CcSEcCtD
Hydrocortisone—CYP3A5—Metabolism—CYP2S1—psoriasis	4.32e-06	0.000654	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.3e-06	9.36e-05	CcSEcCtD
Hydrocortisone—Urticaria—Cyclosporine—psoriasis	4.28e-06	9.32e-05	CcSEcCtD
Hydrocortisone—Myalgia—Betamethasone—psoriasis	4.27e-06	9.29e-05	CcSEcCtD
Hydrocortisone—Myalgia—Dexamethasone—psoriasis	4.27e-06	9.29e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Cyclosporine—psoriasis	4.26e-06	9.27e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Cyclosporine—psoriasis	4.26e-06	9.27e-05	CcSEcCtD
Hydrocortisone—Anxiety—Dexamethasone—psoriasis	4.25e-06	9.26e-05	CcSEcCtD
Hydrocortisone—Anxiety—Betamethasone—psoriasis	4.25e-06	9.26e-05	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—CAT—psoriasis	4.24e-06	0.000641	CbGpPWpGaD
Hydrocortisone—Vomiting—Mycophenolic acid—psoriasis	4.23e-06	9.22e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCL8—psoriasis	4.22e-06	0.000638	CbGpPWpGaD
Hydrocortisone—Discomfort—Betamethasone—psoriasis	4.21e-06	9.18e-05	CcSEcCtD
Hydrocortisone—Discomfort—Dexamethasone—psoriasis	4.21e-06	9.18e-05	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—psoriasis	4.21e-06	9.17e-05	CcSEcCtD
Hydrocortisone—Rash—Mycophenolic acid—psoriasis	4.2e-06	9.14e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Mycophenolic acid—psoriasis	4.19e-06	9.14e-05	CcSEcCtD
Hydrocortisone—Pain—Prednisolone—psoriasis	4.19e-06	9.13e-05	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—psoriasis	4.19e-06	9.13e-05	CcSEcCtD
Hydrocortisone—Urticaria—Mycophenolate mofetil—psoriasis	4.17e-06	9.09e-05	CcSEcCtD
Hydrocortisone—Headache—Mycophenolic acid—psoriasis	4.17e-06	9.08e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Mycophenolate mofetil—psoriasis	4.15e-06	9.05e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Mycophenolate mofetil—psoriasis	4.15e-06	9.05e-05	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	4.15e-06	0.000627	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.11e-06	0.000621	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.11e-06	8.94e-05	CcSEcCtD
Hydrocortisone—Oedema—Betamethasone—psoriasis	4.09e-06	8.91e-05	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Betamethasone—psoriasis	4.09e-06	8.91e-05	CcSEcCtD
Hydrocortisone—Oedema—Dexamethasone—psoriasis	4.09e-06	8.91e-05	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Dexamethasone—psoriasis	4.09e-06	8.91e-05	CcSEcCtD
Hydrocortisone—Insomnia—Triamcinolone—psoriasis	4.08e-06	8.88e-05	CcSEcCtD
Hydrocortisone—Infection—Betamethasone—psoriasis	4.06e-06	8.85e-05	CcSEcCtD
Hydrocortisone—Infection—Dexamethasone—psoriasis	4.06e-06	8.85e-05	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Prednisone—psoriasis	4.05e-06	8.82e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Triamcinolone—psoriasis	4.05e-06	8.82e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Prednisolone—psoriasis	4.04e-06	8.8e-05	CcSEcCtD
Hydrocortisone—Shock—Betamethasone—psoriasis	4.02e-06	8.76e-05	CcSEcCtD
Hydrocortisone—Shock—Dexamethasone—psoriasis	4.02e-06	8.76e-05	CcSEcCtD
Hydrocortisone—Nervous system disorder—Dexamethasone—psoriasis	4.01e-06	8.74e-05	CcSEcCtD
Hydrocortisone—Nervous system disorder—Betamethasone—psoriasis	4.01e-06	8.74e-05	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.99e-06	0.000604	CbGpPWpGaD
Hydrocortisone—Tachycardia—Betamethasone—psoriasis	3.99e-06	8.69e-05	CcSEcCtD
Hydrocortisone—Tachycardia—Dexamethasone—psoriasis	3.99e-06	8.69e-05	CcSEcCtD
Hydrocortisone—Angioedema—Prednisone—psoriasis	3.99e-06	8.69e-05	CcSEcCtD
Hydrocortisone—Hypersensitivity—Cyclosporine—psoriasis	3.97e-06	8.64e-05	CcSEcCtD
Hydrocortisone—Dyspepsia—Triamcinolone—psoriasis	3.97e-06	8.64e-05	CcSEcCtD
Hydrocortisone—Nausea—Mycophenolic acid—psoriasis	3.95e-06	8.61e-05	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Betamethasone—psoriasis	3.95e-06	8.61e-05	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Dexamethasone—psoriasis	3.95e-06	8.61e-05	CcSEcCtD
Hydrocortisone—Malaise—Prednisone—psoriasis	3.93e-06	8.57e-05	CcSEcCtD
Hydrocortisone—Vertigo—Prednisone—psoriasis	3.92e-06	8.54e-05	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—psoriasis	3.91e-06	8.53e-05	CcSEcCtD
Hydrocortisone—Syncope—Prednisone—psoriasis	3.91e-06	8.52e-05	CcSEcCtD
Hydrocortisone—Anorexia—Betamethasone—psoriasis	3.9e-06	8.49e-05	CcSEcCtD
Hydrocortisone—Anorexia—Dexamethasone—psoriasis	3.9e-06	8.49e-05	CcSEcCtD
Hydrocortisone—Urticaria—Prednisolone—psoriasis	3.89e-06	8.48e-05	CcSEcCtD
Hydrocortisone—Fatigue—Triamcinolone—psoriasis	3.89e-06	8.46e-05	CcSEcCtD
Hydrocortisone—NR3C1—Adipogenesis—IL6—psoriasis	3.87e-06	0.000586	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Mycophenolate mofetil—psoriasis	3.87e-06	8.43e-05	CcSEcCtD
Hydrocortisone—Asthenia—Cyclosporine—psoriasis	3.86e-06	8.42e-05	CcSEcCtD
Hydrocortisone—Pain—Triamcinolone—psoriasis	3.85e-06	8.4e-05	CcSEcCtD
Hydrocortisone—ABCB1—Allograft Rejection—TNF—psoriasis	3.84e-06	0.000581	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—NDUFA5—psoriasis	3.84e-06	0.00058	CbGpPWpGaD
Hydrocortisone—Loss of consciousness—Prednisone—psoriasis	3.84e-06	8.35e-05	CcSEcCtD
Hydrocortisone—Hypotension—Dexamethasone—psoriasis	3.82e-06	8.32e-05	CcSEcCtD
Hydrocortisone—Hypotension—Betamethasone—psoriasis	3.82e-06	8.32e-05	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.82e-06	0.000577	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—CARM1—psoriasis	3.82e-06	0.000577	CbGpPWpGaD
Hydrocortisone—Pruritus—Cyclosporine—psoriasis	3.81e-06	8.3e-05	CcSEcCtD
Hydrocortisone—Immune system disorder—Methotrexate—psoriasis	3.78e-06	8.24e-05	CcSEcCtD
Hydrocortisone—Convulsion—Prednisone—psoriasis	3.78e-06	8.24e-05	CcSEcCtD
Hydrocortisone—Asthenia—Mycophenolate mofetil—psoriasis	3.77e-06	8.21e-05	CcSEcCtD
Hydrocortisone—Hypertension—Prednisone—psoriasis	3.77e-06	8.21e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—APOE—psoriasis	3.75e-06	0.000567	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—LEP—psoriasis	3.75e-06	0.000567	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CYP2S1—psoriasis	3.75e-06	0.000567	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Betamethasone—psoriasis	3.73e-06	8.12e-05	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.73e-06	8.12e-05	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism—CARM1—psoriasis	3.72e-06	0.000563	CbGpPWpGaD
Hydrocortisone—Pruritus—Mycophenolate mofetil—psoriasis	3.72e-06	8.1e-05	CcSEcCtD
Hydrocortisone—Myalgia—Prednisone—psoriasis	3.71e-06	8.09e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Triamcinolone—psoriasis	3.71e-06	8.09e-05	CcSEcCtD
Hydrocortisone—Anxiety—Prednisone—psoriasis	3.7e-06	8.06e-05	CcSEcCtD
Hydrocortisone—Insomnia—Dexamethasone—psoriasis	3.7e-06	8.06e-05	CcSEcCtD
Hydrocortisone—Insomnia—Betamethasone—psoriasis	3.7e-06	8.06e-05	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.69e-06	8.04e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Cyclosporine—psoriasis	3.68e-06	8.03e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Betamethasone—psoriasis	3.67e-06	8e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Dexamethasone—psoriasis	3.67e-06	8e-05	CcSEcCtD
Hydrocortisone—Discomfort—Prednisone—psoriasis	3.67e-06	8e-05	CcSEcCtD
Hydrocortisone—Mental disorder—Methotrexate—psoriasis	3.67e-06	7.99e-05	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—CAT—psoriasis	3.65e-06	0.000552	CbGpPWpGaD
Hydrocortisone—Erythema—Methotrexate—psoriasis	3.65e-06	7.94e-05	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—psoriasis	3.65e-06	7.94e-05	CcSEcCtD
Hydrocortisone—Hypersensitivity—Prednisolone—psoriasis	3.61e-06	7.87e-05	CcSEcCtD
Hydrocortisone—Dyspepsia—Betamethasone—psoriasis	3.6e-06	7.84e-05	CcSEcCtD
Hydrocortisone—Dyspepsia—Dexamethasone—psoriasis	3.6e-06	7.84e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Mycophenolate mofetil—psoriasis	3.59e-06	7.83e-05	CcSEcCtD
Hydrocortisone—Urticaria—Triamcinolone—psoriasis	3.58e-06	7.8e-05	CcSEcCtD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.57e-06	0.000539	CbGpPWpGaD
Hydrocortisone—Body temperature increased—Triamcinolone—psoriasis	3.56e-06	7.76e-05	CcSEcCtD
Hydrocortisone—Dizziness—Cyclosporine—psoriasis	3.56e-06	7.76e-05	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Prednisone—psoriasis	3.56e-06	7.76e-05	CcSEcCtD
Hydrocortisone—Oedema—Prednisone—psoriasis	3.56e-06	7.76e-05	CcSEcCtD
Hydrocortisone—Decreased appetite—Betamethasone—psoriasis	3.55e-06	7.74e-05	CcSEcCtD
Hydrocortisone—Decreased appetite—Dexamethasone—psoriasis	3.55e-06	7.74e-05	CcSEcCtD
Hydrocortisone—Infection—Prednisone—psoriasis	3.54e-06	7.71e-05	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Dexamethasone—psoriasis	3.53e-06	7.69e-05	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Betamethasone—psoriasis	3.53e-06	7.69e-05	CcSEcCtD
Hydrocortisone—Fatigue—Betamethasone—psoriasis	3.53e-06	7.68e-05	CcSEcCtD
Hydrocortisone—Fatigue—Dexamethasone—psoriasis	3.53e-06	7.68e-05	CcSEcCtD
Hydrocortisone—Shock—Prednisone—psoriasis	3.5e-06	7.63e-05	CcSEcCtD
Hydrocortisone—Pain—Dexamethasone—psoriasis	3.5e-06	7.62e-05	CcSEcCtD
Hydrocortisone—Pain—Betamethasone—psoriasis	3.5e-06	7.62e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—NFKBIA—psoriasis	3.5e-06	0.000529	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Prednisone—psoriasis	3.49e-06	7.61e-05	CcSEcCtD
Hydrocortisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.48e-06	0.000526	CbGpPWpGaD
Hydrocortisone—Tachycardia—Prednisone—psoriasis	3.48e-06	7.57e-05	CcSEcCtD
Hydrocortisone—Dizziness—Mycophenolate mofetil—psoriasis	3.47e-06	7.57e-05	CcSEcCtD
Hydrocortisone—Skin disorder—Prednisone—psoriasis	3.46e-06	7.54e-05	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Prednisone—psoriasis	3.44e-06	7.5e-05	CcSEcCtD
Hydrocortisone—Vomiting—Cyclosporine—psoriasis	3.42e-06	7.46e-05	CcSEcCtD
Hydrocortisone—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.4e-06	0.000515	CbGpPWpGaD
Hydrocortisone—Rash—Cyclosporine—psoriasis	3.4e-06	7.4e-05	CcSEcCtD
Hydrocortisone—Anorexia—Prednisone—psoriasis	3.39e-06	7.39e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Cyclosporine—psoriasis	3.39e-06	7.39e-05	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Methotrexate—psoriasis	3.38e-06	7.37e-05	CcSEcCtD
Hydrocortisone—Headache—Cyclosporine—psoriasis	3.37e-06	7.35e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Betamethasone—psoriasis	3.37e-06	7.34e-05	CcSEcCtD
Hydrocortisone—Feeling abnormal—Dexamethasone—psoriasis	3.37e-06	7.34e-05	CcSEcCtD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	3.35e-06	0.000506	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Dexamethasone—psoriasis	3.34e-06	7.28e-05	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Betamethasone—psoriasis	3.34e-06	7.28e-05	CcSEcCtD
Hydrocortisone—Vomiting—Mycophenolate mofetil—psoriasis	3.34e-06	7.28e-05	CcSEcCtD
Hydrocortisone—Hypersensitivity—Triamcinolone—psoriasis	3.32e-06	7.23e-05	CcSEcCtD
Hydrocortisone—Rash—Mycophenolate mofetil—psoriasis	3.31e-06	7.22e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Mycophenolate mofetil—psoriasis	3.31e-06	7.21e-05	CcSEcCtD
Hydrocortisone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	3.3e-06	0.000499	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—APOE—psoriasis	3.29e-06	0.000498	CbGpPWpGaD
Hydrocortisone—Headache—Mycophenolate mofetil—psoriasis	3.29e-06	7.17e-05	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—psoriasis	3.29e-06	7.16e-05	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—psoriasis	3.28e-06	7.14e-05	CcSEcCtD
Hydrocortisone—ABCB1—Metabolism—CYP2S1—psoriasis	3.26e-06	0.000494	CbGpPWpGaD
Hydrocortisone—Urticaria—Betamethasone—psoriasis	3.25e-06	7.08e-05	CcSEcCtD
Hydrocortisone—Urticaria—Dexamethasone—psoriasis	3.25e-06	7.08e-05	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Prednisone—psoriasis	3.24e-06	7.07e-05	CcSEcCtD
Hydrocortisone—Dizziness—Prednisolone—psoriasis	3.24e-06	7.06e-05	CcSEcCtD
Hydrocortisone—Asthenia—Triamcinolone—psoriasis	3.23e-06	7.04e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Betamethasone—psoriasis	3.23e-06	7.04e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Betamethasone—psoriasis	3.23e-06	7.04e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Dexamethasone—psoriasis	3.23e-06	7.04e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Dexamethasone—psoriasis	3.23e-06	7.04e-05	CcSEcCtD
Hydrocortisone—Insomnia—Prednisone—psoriasis	3.22e-06	7.02e-05	CcSEcCtD
Hydrocortisone—Nausea—Cyclosporine—psoriasis	3.2e-06	6.97e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Prednisone—psoriasis	3.2e-06	6.97e-05	CcSEcCtD
Hydrocortisone—Pruritus—Triamcinolone—psoriasis	3.19e-06	6.95e-05	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—psoriasis	3.16e-06	6.88e-05	CcSEcCtD
Hydrocortisone—Dyspepsia—Prednisone—psoriasis	3.13e-06	6.83e-05	CcSEcCtD
Hydrocortisone—Nausea—Mycophenolate mofetil—psoriasis	3.12e-06	6.8e-05	CcSEcCtD
Hydrocortisone—Myalgia—Methotrexate—psoriasis	3.1e-06	6.76e-05	CcSEcCtD
Hydrocortisone—Decreased appetite—Prednisone—psoriasis	3.1e-06	6.74e-05	CcSEcCtD
Hydrocortisone—Rash—Prednisolone—psoriasis	3.09e-06	6.73e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Prednisolone—psoriasis	3.09e-06	6.73e-05	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.08e-06	6.72e-05	CcSEcCtD
Hydrocortisone—Fatigue—Prednisone—psoriasis	3.07e-06	6.69e-05	CcSEcCtD
Hydrocortisone—Headache—Prednisolone—psoriasis	3.07e-06	6.69e-05	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—psoriasis	3.07e-06	6.68e-05	CcSEcCtD
Hydrocortisone—Dizziness—Triamcinolone—psoriasis	2.98e-06	6.49e-05	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Methotrexate—psoriasis	2.98e-06	6.48e-05	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—psoriasis	2.96e-06	6.44e-05	CcSEcCtD
Hydrocortisone—ABCG2—Metabolism—CARM1—psoriasis	2.95e-06	0.000446	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Prednisone—psoriasis	2.93e-06	6.39e-05	CcSEcCtD
Hydrocortisone—Asthenia—Betamethasone—psoriasis	2.93e-06	6.39e-05	CcSEcCtD
Hydrocortisone—Asthenia—Dexamethasone—psoriasis	2.93e-06	6.39e-05	CcSEcCtD
Hydrocortisone—CYP3A7—Metabolism—CARM1—psoriasis	2.92e-06	0.000442	CbGpPWpGaD
Hydrocortisone—Nervous system disorder—Methotrexate—psoriasis	2.92e-06	6.36e-05	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Prednisone—psoriasis	2.91e-06	6.34e-05	CcSEcCtD
Hydrocortisone—Nausea—Prednisolone—psoriasis	2.91e-06	6.34e-05	CcSEcCtD
Hydrocortisone—Pruritus—Betamethasone—psoriasis	2.89e-06	6.3e-05	CcSEcCtD
Hydrocortisone—Pruritus—Dexamethasone—psoriasis	2.89e-06	6.3e-05	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—psoriasis	2.89e-06	6.3e-05	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—psoriasis	2.88e-06	6.27e-05	CcSEcCtD
Hydrocortisone—CYP11B2—Metabolism—PPARG—psoriasis	2.87e-06	0.000434	CbGpPWpGaD
Hydrocortisone—Vomiting—Triamcinolone—psoriasis	2.87e-06	6.24e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—TYK2—psoriasis	2.86e-06	0.000433	CbGpPWpGaD
Hydrocortisone—Rash—Triamcinolone—psoriasis	2.84e-06	6.19e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Triamcinolone—psoriasis	2.84e-06	6.18e-05	CcSEcCtD
Hydrocortisone—CYP11B1—Metabolism—APOE—psoriasis	2.84e-06	0.000429	CbGpPWpGaD
Hydrocortisone—Anorexia—Methotrexate—psoriasis	2.84e-06	6.18e-05	CcSEcCtD
Hydrocortisone—Urticaria—Prednisone—psoriasis	2.83e-06	6.16e-05	CcSEcCtD
Hydrocortisone—Headache—Triamcinolone—psoriasis	2.82e-06	6.15e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Prednisone—psoriasis	2.82e-06	6.13e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Prednisone—psoriasis	2.82e-06	6.13e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Betamethasone—psoriasis	2.8e-06	6.09e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Dexamethasone—psoriasis	2.8e-06	6.09e-05	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—psoriasis	2.78e-06	6.06e-05	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—psoriasis	2.71e-06	5.91e-05	CcSEcCtD
Hydrocortisone—Dizziness—Dexamethasone—psoriasis	2.7e-06	5.89e-05	CcSEcCtD
Hydrocortisone—Dizziness—Betamethasone—psoriasis	2.7e-06	5.89e-05	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—psoriasis	2.69e-06	5.86e-05	CcSEcCtD
Hydrocortisone—Nausea—Triamcinolone—psoriasis	2.68e-06	5.83e-05	CcSEcCtD
Hydrocortisone—Paraesthesia—Methotrexate—psoriasis	2.67e-06	5.82e-05	CcSEcCtD
Hydrocortisone—Hypersensitivity—Prednisone—psoriasis	2.62e-06	5.72e-05	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—psoriasis	2.62e-06	5.71e-05	CcSEcCtD
Hydrocortisone—Vomiting—Dexamethasone—psoriasis	2.6e-06	5.66e-05	CcSEcCtD
Hydrocortisone—Vomiting—Betamethasone—psoriasis	2.6e-06	5.66e-05	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—psoriasis	2.59e-06	5.64e-05	CcSEcCtD
Hydrocortisone—Rash—Betamethasone—psoriasis	2.58e-06	5.62e-05	CcSEcCtD
Hydrocortisone—Rash—Dexamethasone—psoriasis	2.58e-06	5.62e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Dexamethasone—psoriasis	2.58e-06	5.61e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Betamethasone—psoriasis	2.58e-06	5.61e-05	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—psoriasis	2.57e-06	5.6e-05	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—psoriasis	2.57e-06	5.59e-05	CcSEcCtD
Hydrocortisone—Headache—Dexamethasone—psoriasis	2.56e-06	5.58e-05	CcSEcCtD
Hydrocortisone—Headache—Betamethasone—psoriasis	2.56e-06	5.58e-05	CcSEcCtD
Hydrocortisone—Asthenia—Prednisone—psoriasis	2.56e-06	5.57e-05	CcSEcCtD
Hydrocortisone—Pain—Methotrexate—psoriasis	2.55e-06	5.54e-05	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.53e-06	0.000383	CbGpPWpGaD
Hydrocortisone—Pruritus—Prednisone—psoriasis	2.52e-06	5.49e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—CXCL8—psoriasis	2.49e-06	0.000377	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PPARG—psoriasis	2.47e-06	0.000374	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Methotrexate—psoriasis	2.45e-06	5.34e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Prednisone—psoriasis	2.44e-06	5.31e-05	CcSEcCtD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.44e-06	0.000368	CbGpPWpGaD
Hydrocortisone—Gastrointestinal pain—Methotrexate—psoriasis	2.43e-06	5.3e-05	CcSEcCtD
Hydrocortisone—Nausea—Dexamethasone—psoriasis	2.43e-06	5.29e-05	CcSEcCtD
Hydrocortisone—Nausea—Betamethasone—psoriasis	2.43e-06	5.29e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling by GPCR—IL6—psoriasis	2.37e-06	0.000358	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—NDUFA5—psoriasis	2.36e-06	0.000358	CbGpPWpGaD
Hydrocortisone—Urticaria—Methotrexate—psoriasis	2.36e-06	5.15e-05	CcSEcCtD
Hydrocortisone—Dizziness—Prednisone—psoriasis	2.35e-06	5.13e-05	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—psoriasis	2.35e-06	5.13e-05	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—psoriasis	2.35e-06	5.13e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—JUN—psoriasis	2.32e-06	0.00035	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—CAT—psoriasis	2.29e-06	0.000346	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—VDR—psoriasis	2.28e-06	0.000345	CbGpPWpGaD
Hydrocortisone—Vomiting—Prednisone—psoriasis	2.26e-06	4.93e-05	CcSEcCtD
Hydrocortisone—Rash—Prednisone—psoriasis	2.25e-06	4.89e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Prednisone—psoriasis	2.24e-06	4.89e-05	CcSEcCtD
Hydrocortisone—Headache—Prednisone—psoriasis	2.23e-06	4.86e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—NFKB1—psoriasis	2.23e-06	0.000337	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.21e-06	0.000334	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Methotrexate—psoriasis	2.19e-06	4.78e-05	CcSEcCtD
Hydrocortisone—Asthenia—Methotrexate—psoriasis	2.14e-06	4.65e-05	CcSEcCtD
Hydrocortisone—Nausea—Prednisone—psoriasis	2.12e-06	4.61e-05	CcSEcCtD
Hydrocortisone—CYP3A5—Metabolism—CARM1—psoriasis	2.11e-06	0.000319	CbGpPWpGaD
Hydrocortisone—Pruritus—Methotrexate—psoriasis	2.11e-06	4.59e-05	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—psoriasis	2.04e-06	4.44e-05	CcSEcCtD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—psoriasis	2.02e-06	0.000306	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CYP2S1—psoriasis	2.01e-06	0.000304	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—STAT3—psoriasis	2e-06	0.000303	CbGpPWpGaD
Hydrocortisone—Dizziness—Methotrexate—psoriasis	1.97e-06	4.29e-05	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.96e-06	0.000297	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.89e-06	0.000287	CbGpPWpGaD
Hydrocortisone—Vomiting—Methotrexate—psoriasis	1.89e-06	4.12e-05	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—psoriasis	1.88e-06	4.09e-05	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—psoriasis	1.87e-06	4.08e-05	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—psoriasis	1.86e-06	4.06e-05	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism—CARM1—psoriasis	1.83e-06	0.000277	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—CAT—psoriasis	1.81e-06	0.000274	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—CAT—psoriasis	1.8e-06	0.000272	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—APOE—psoriasis	1.78e-06	0.000269	CbGpPWpGaD
Hydrocortisone—Nausea—Methotrexate—psoriasis	1.77e-06	3.85e-05	CcSEcCtD
Hydrocortisone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.71e-06	0.000259	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.67e-06	0.000253	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CARM1—psoriasis	1.59e-06	0.000241	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—PPARG—psoriasis	1.59e-06	0.00024	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PPARG—psoriasis	1.55e-06	0.000234	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—psoriasis	1.53e-06	0.000231	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—APOE—psoriasis	1.41e-06	0.000213	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL6—psoriasis	1.4e-06	0.000212	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—APOE—psoriasis	1.4e-06	0.000211	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—CAT—psoriasis	1.3e-06	0.000196	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PPARG—psoriasis	1.23e-06	0.000186	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PPARG—psoriasis	1.22e-06	0.000184	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—CAT—psoriasis	1.13e-06	0.00017	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—APOE—psoriasis	1.01e-06	0.000153	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CARM1—psoriasis	9.82e-07	0.000149	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—CAT—psoriasis	9.8e-07	0.000148	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PPARG—psoriasis	8.79e-07	0.000133	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—APOE—psoriasis	8.74e-07	0.000132	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—APOE—psoriasis	7.62e-07	0.000115	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PPARG—psoriasis	7.61e-07	0.000115	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PPARG—psoriasis	6.63e-07	0.0001	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—CAT—psoriasis	6.04e-07	9.13e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—APOE—psoriasis	4.69e-07	7.1e-05	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PPARG—psoriasis	4.09e-07	6.18e-05	CbGpPWpGaD
